Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review

About 45:000 cancers are linked to HPV each year in the United States alone. The HPV vaccine prevents cancer and is highly effective, yet vaccination coverage remains low. Pharmacies can play a meaningful role in increasing HPV vaccination access due to their availability and convenience. However, l...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Oluwafemifola Oyedeji, Jill M. Maples, Samantha Gregory, Shauntá M. Chamberlin, Justin D. Gatwood, Alexandria Q. Wilson, Nikki B. Zite, Larry C. Kilgore
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	Human Papillomavirus barriers pharmacists vaccination Medicine R
Acceso en línea:	https://doaj.org/article/d972e16d89da4af1b1355175a9883f0c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d972e16d89da4af1b1355175a9883f0c
record_format	dspace
spelling	oai:doaj.org-article:d972e16d89da4af1b1355175a9883f0c2021-11-25T19:11:37ZPharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review10.3390/vaccines91113602076-393Xhttps://doaj.org/article/d972e16d89da4af1b1355175a9883f0c2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-393X/9/11/1360https://doaj.org/toc/2076-393XAbout 45:000 cancers are linked to HPV each year in the United States alone. The HPV vaccine prevents cancer and is highly effective, yet vaccination coverage remains low. Pharmacies can play a meaningful role in increasing HPV vaccination access due to their availability and convenience. However, little is known about pharmacists’ perceived barriers to HPV vaccination. The objective of this systematic review was to summarize existing literature on perceived barriers to administering HPV vaccination reported by pharmacists. Barriers identified from selected studies were synthesized and further grouped into patient, parental, (pharmacist’s) personal, and system/organization barrier groups. Six studies were included in this review. The cost of the HPV vaccine, insurance coverage and reimbursement were commonly reported perceived barriers. Adolescent HPV vaccination barriers related to parental concerns, beliefs, and inadequate knowledge about the HPV vaccine. Perceived (pharmacist’s) personal barriers were related to lack of information and knowledge about HPV vaccine and recommendations. At the system/organization level, barriers reported included lack of time/staff/space; difficulty in series completion; tracking and recall of patient; perceived competition with providers; and other responsibilities/vaccines taking precedence. Future strategies involving pharmacy settings in HPV-related cancer prevention efforts should consider research on multilevel pharmacy-driven interventions addressing barriers.Oluwafemifola OyedejiJill M. MaplesSamantha GregoryShauntá M. ChamberlinJustin D. GatwoodAlexandria Q. WilsonNikki B. ZiteLarry C. KilgoreMDPI AGarticleHuman PapillomavirusbarrierspharmacistsvaccinationMedicineRENVaccines, Vol 9, Iss 1360, p 1360 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Human Papillomavirus barriers pharmacists vaccination Medicine R
spellingShingle	Human Papillomavirus barriers pharmacists vaccination Medicine R Oluwafemifola Oyedeji Jill M. Maples Samantha Gregory Shauntá M. Chamberlin Justin D. Gatwood Alexandria Q. Wilson Nikki B. Zite Larry C. Kilgore Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review
description	About 45:000 cancers are linked to HPV each year in the United States alone. The HPV vaccine prevents cancer and is highly effective, yet vaccination coverage remains low. Pharmacies can play a meaningful role in increasing HPV vaccination access due to their availability and convenience. However, little is known about pharmacists’ perceived barriers to HPV vaccination. The objective of this systematic review was to summarize existing literature on perceived barriers to administering HPV vaccination reported by pharmacists. Barriers identified from selected studies were synthesized and further grouped into patient, parental, (pharmacist’s) personal, and system/organization barrier groups. Six studies were included in this review. The cost of the HPV vaccine, insurance coverage and reimbursement were commonly reported perceived barriers. Adolescent HPV vaccination barriers related to parental concerns, beliefs, and inadequate knowledge about the HPV vaccine. Perceived (pharmacist’s) personal barriers were related to lack of information and knowledge about HPV vaccine and recommendations. At the system/organization level, barriers reported included lack of time/staff/space; difficulty in series completion; tracking and recall of patient; perceived competition with providers; and other responsibilities/vaccines taking precedence. Future strategies involving pharmacy settings in HPV-related cancer prevention efforts should consider research on multilevel pharmacy-driven interventions addressing barriers.
format	article
author	Oluwafemifola Oyedeji Jill M. Maples Samantha Gregory Shauntá M. Chamberlin Justin D. Gatwood Alexandria Q. Wilson Nikki B. Zite Larry C. Kilgore
author_facet	Oluwafemifola Oyedeji Jill M. Maples Samantha Gregory Shauntá M. Chamberlin Justin D. Gatwood Alexandria Q. Wilson Nikki B. Zite Larry C. Kilgore
author_sort	Oluwafemifola Oyedeji
title	Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review
title_short	Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review
title_full	Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review
title_fullStr	Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review
title_full_unstemmed	Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review
title_sort	pharmacists’ perceived barriers to human papillomavirus (hpv) vaccination: a systematic literature review
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/d972e16d89da4af1b1355175a9883f0c
work_keys_str_mv	AT oluwafemifolaoyedeji pharmacistsperceivedbarrierstohumanpapillomavirushpvvaccinationasystematicliteraturereview AT jillmmaples pharmacistsperceivedbarrierstohumanpapillomavirushpvvaccinationasystematicliteraturereview AT samanthagregory pharmacistsperceivedbarrierstohumanpapillomavirushpvvaccinationasystematicliteraturereview AT shauntamchamberlin pharmacistsperceivedbarrierstohumanpapillomavirushpvvaccinationasystematicliteraturereview AT justindgatwood pharmacistsperceivedbarrierstohumanpapillomavirushpvvaccinationasystematicliteraturereview AT alexandriaqwilson pharmacistsperceivedbarrierstohumanpapillomavirushpvvaccinationasystematicliteraturereview AT nikkibzite pharmacistsperceivedbarrierstohumanpapillomavirushpvvaccinationasystematicliteraturereview AT larryckilgore pharmacistsperceivedbarrierstohumanpapillomavirushpvvaccinationasystematicliteraturereview
_version_	1718410185626615808

Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review

Ejemplares similares